Duodenal and antral mucosal prostaglandin E2 synthesis in a study of normal subjects and all stages of duodenal ulcer disease treated by H2 receptor antagonists
about
Reduced tissue type plasminogen activator activity of the gastroduodenal mucosa in peptic ulcer disease.Patients with adenomatous polyps and carcinomas have increased colonic mucosal prostaglandin E2Circadian pattern of intragastric acidity in duodenal ulcer patients: a study of variations in relation to ulcer activity.
P2860
Duodenal and antral mucosal prostaglandin E2 synthesis in a study of normal subjects and all stages of duodenal ulcer disease treated by H2 receptor antagonists
description
1989 nî lūn-bûn
@nan
1989 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Duodenal and antral mucosal pr ...... ted by H2 receptor antagonists
@ast
Duodenal and antral mucosal pr ...... ted by H2 receptor antagonists
@en
Duodenal and antral mucosal pr ...... ted by H2 receptor antagonists
@nl
type
label
Duodenal and antral mucosal pr ...... ted by H2 receptor antagonists
@ast
Duodenal and antral mucosal pr ...... ted by H2 receptor antagonists
@en
Duodenal and antral mucosal pr ...... ted by H2 receptor antagonists
@nl
prefLabel
Duodenal and antral mucosal pr ...... ted by H2 receptor antagonists
@ast
Duodenal and antral mucosal pr ...... ted by H2 receptor antagonists
@en
Duodenal and antral mucosal pr ...... ted by H2 receptor antagonists
@nl
P2093
P2860
P356
P1433
P1476
Duodenal and antral mucosal pr ...... ted by H2 receptor antagonists
@en
P2093
Bardhan KD
Williams SE
P2860
P304
P356
10.1136/GUT.30.2.161
P407
P577
1989-02-01T00:00:00Z